---
title: "MIRA Pharmaceuticals, Inc. (MIRA.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/MIRA.US.md"
symbol: "MIRA.US"
name: "MIRA Pharmaceuticals, Inc."
industry: "Pharmaceuticals"
---

# MIRA Pharmaceuticals, Inc. (MIRA.US)

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Location | US Market |
| Website | [mirapharmaceuticals.com](https://mirapharmaceuticals.com) |

## Company Profile

MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine a...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -1.75 | 127/257 | - | - | - |
| PB | 6.60 | 156/257 | 44.17 | 14.77 | 6.86 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-12-18T05:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.19 |
| Highest Target | 17.75 |
| Lowest Target | 17.75 |

## References

- [Company Overview](https://longbridge.com/en/quote/MIRA.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/MIRA.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/MIRA.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.